Skip to content
healthcare.dev

Renal Drops 5024

NDC 63083-5024, Renal Drops, liquid, from Professional Complementary Health Formulas.

Product NDC
63083-5024
Status
Listed
Labeler
Professional Complementary Health Formulas
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63083-5024 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RUBIA TINCTORUM ROOT1 [hp_X]/59mL
  • URTICA URENS WHOLE1 [hp_X]/59mL
  • LYCOPODIUM CLAVATUM SPORE2 [hp_X]/59mL
  • SMILAX ORNATA ROOT3 [hp_X]/59mL
  • BENZOIC ACID4 [hp_X]/59mL
  • LITHIUM CARBONATE4 [hp_X]/59mL
  • BERBERIS VULGARIS ROOT BARK5 [hp_X]/59mL
  • PROTORTONIA CACTI5 [hp_X]/59mL
  • SILVER NITRATE6 [hp_X]/59mL
  • ATROPINE SULFATE6 [hp_X]/59mL
  • CITRULLUS COLOCYNTHIS FRUIT PULP6 [hp_X]/59mL
  • BEEF KIDNEY6 [hp_X]/59mL
  • PETROSELINUM CRISPUM ROOT6 [hp_X]/59mL
  • TARAXACUM OFFICINALE6 [hp_X]/59mL
  • CALCIUM HEXAFLUOROSILICATE10 [hp_X]/59mL
  • OYSTER SHELL CALCIUM CARBONATE, CRUDE12 [hp_X]/59mL

Pharmacologic classes

Ammonium Ion Binding Activity [MoA]; Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]; Mood Stabilizer [EPC]; Nitrogen Binding Agent [EPC]

Package NDCNDC-11Package
63083-5024-26308350240259 mL in 1 BOTTLE, DROPPER (63083-5024-2)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 63083-5024 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63083-5024 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63083-5024. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.